Unexpected Result: COVID-19 Vaccination Improves Effectiveness of Cancer Treatment
Excerpt from the Press Release:
Clinical study on nasopharyngeal cancer with an unexpected result.
Patients with nasopharyngeal cancer are often treated with drugs that activate their immune system against the tumor. Scientists feared that vaccination against COVID-19 could reduce the success of cancer treatment or cause severe side effects—until now. A recent study now gives the all-clear in this regard. According to the study, the cancer drugs actually worked better after vaccination with the Chinese vaccine SinoVac than in unvaccinated patients.
The results of the study, which was conducted by the Universities of Bonn and Shanxi in the People’s Republic of China, are published as a “Letter to the editor” in the journal Annals of Oncology, but are already available online.
Many cancer cells are capable of subverting the body’s immune response. They do this by pushing a kind of button on the immune cells, the PD-1 receptor. In this way, they effectively shut down these endogenous defense forces. Drugs can be used to block PD-1 receptors. This enables the immune system to fight the tumor more effectively.
Click the button below to read the entire Press Release:
Discover What Sets TrialStat Apart From Ordinary EDC Platforms
Click the image or button below to explore our eClinical Suite Platform and discover what sets TrialStat apart from competing EDC platforms.
Request Your Demo Today!
From rapid database build through database lock, we deliver consistent quality on-time and on-budget. Ready to upgrade your eClinical toolkit?